🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 15

  1. US 12023389

    Compositions that target tumor-associated macrophages and methods of use therefor

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12024509

    Therapeutic compounds as inhibitors of the orexin-1 receptor

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12006321

    Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11998576

    Direct-fed microbials

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11981752

    Tumor associated monocyte/macrophage binding peptide and methods of use thereof

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11979133

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11964960

    Pyridinone- and pyridazinone-based compounds and uses thereof

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11958862

    Compounds and compositions and uses thereof

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11944656

    Microbials for feed

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11945822

    Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11939367

    BTLA fusion protein agonists and uses thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11932600

    Biaryl derivative

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11918568

    Fused ring compound having urea structure

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11912786

    Inhibitor of apoptosis protein (IAP) antagonists

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11905268

    Anthranilic acid derivatives and their use in the treatment of human cancers

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11903920

    Cannabinoid formulation: production method and use

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11905276

    Bicyclic compound that acts as CRBN protein regulator

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11891399

    Inhibitors of cancer invasion, attachment, and/or metastasis

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11891626

    Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11883359

    Adapter for use in a planetary mixer

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11858937

    Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11859021

    Compounds for regulating trained immunity, and their methods of use

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11851479

    Methods and compositions for pertussis diagnosis

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11839676

    System, method, and kit for selecting and preparing customized cosmetics

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11839629

    Methods and compositions to modulate hair growth

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11834515

    Macrocyclic compounds as proteasome inhibitors

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11827616

    Heterocyclic compounds as pesticides

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11827637

    Azaindole derivatives and their use as ERK kinase inhibitors

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11821003

    Cardiogenic mesoderm formation regulators

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11813257

    Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11814371

    Heterocyclic compound

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11807646

    4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11806337

    Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11767334

    Heteroaryl inhibitors of PDE4

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11753398

    Therapeutic compounds

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11731986

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11730820

    Peptidic blocks for nucleic acid delivery

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11732005

    Peptidomimetic proteasome inhibitors

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11718610

    Compounds containing benzosultam

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11708364

    Azaindole derivatives and their use as ERK kinase inhibitors

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11707510

    Nucleic acid-based botulinum neurotoxin for therapeutic use

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11702400

    Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11702478

    Agonistic CD40 antibodies

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11691974

    3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11691987

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11684600

    Composition of active agents to positively affect a robust mammalian endocannabinoid system tone to better address age related discomfort

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11679112

    Cancer treatments using combinations of CDK and ERK inhibitors

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11680070

    Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.